Publication at Faculty of Medicine in Hradec Králové |
2023
Abstract
Multiple sclerosis is a chronic inflammatory autoimmune disease which affect central nervous system. Treatment initiation of early multiple sclerosismay postpone the development of disease progression and disablement.
One of theoal of MS treatmentis state without clinical and subclinical markers of diseaty activity, state known as NEDA (No evidence od disease activity). This work is concerned with parameter NEDA-3 from the point of current treatment of MS.